Cible Skin is a story of vision and family legacy led by Dr. Joël Aknin, a renowned plastic surgeon, and his son, Dr. Raphaël Aknin, a pharmacy expert in skin immunology.
Over ten years ago, this scientific adventure was born from a shared ambition: to reverse cellular aging and rejuvenate the biological age of the skin.
In the laboratories of a biotechnology company, Dr. Raphaël Aknin, then a research director, embarked on the development of regenerative treatments to strengthen and repair the skin of patients undergoing chemotherapy.
By exploring the link between the skin’s immune system and cellular regeneration, he made a major discovery: activating the skin’s immune system can reduce its biological aging.
Back in France, he shared this discovery with his father. Together, by combining their expertise in aesthetic surgery and skin immunology, they created the first science of skin longevity.
From this combination of expertise, Cible Skin was born: the exceptional scientific promise to rejuvenate the biological age of the skin.